Wikidata

(Q79833216)

English

Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload

scientific article published on 01 July 2006

In more languages

Statements

title
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16818273
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16818273%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q79833216&oldid=1584430491"